Market Overview - US stocks experienced a decline heading into the close on Friday, resulting in weekly losses for major indices, with the S&P 500 and Dow Jones Industrial Average posting losses of more than 1% and the Nasdaq falling over 2% [1] Inflation Data - Inflation cooled more than expected in January, with the Consumer Price Index indicating a 0.2% increase from the previous month and a 2.4% increase on an annual basis [2] Federal Reserve Expectations - The inflation report is likely to influence expectations regarding Federal Reserve policy, with traders increasing bets on a potential quarter-point rate cut in June, while most anticipate two cuts by the end of 2026 [3] Sector Performance - Concerns about AI disruption affected various sectors, including real estate, logistics, and transportation, leading to significant selling pressure, particularly in technology stocks, with all seven of the "Magnificent Seven" megacaps closing lower [4] Earnings Reports - Applied Materials (AMAT) saw its stock surge due to a positive outlook driven by strong AI demand, while Pinterest (PINS) shares fell after revenue missed expectations, raising concerns about AI risks to its platform [5] - Rivian (RIVN) shares increased by over 25% following a fourth-quarter earnings beat, with the company on track to deliver its R2 midsize model before summer [6] - Moderna (MRNA) shares rose 10% after exceeding quarterly revenue estimates, attributed to strong sales of its Covid vaccine [6]

Economic Indicators - Inflation cooled more than expected in January, with the Consumer Price Index showing a 0.2% increase from the previous month and a 2.4% increase on an annual basis [2] - The report is likely to influence Federal Reserve policy, with traders reviving bets on a quarter-point rate cut in June, and a majority expecting two cuts by the end of 2026 [3] Market Performance - US stocks experienced wavering performance, with the Dow Jones Industrial Average and Nasdaq Composite drifting below the flatline, while the S&P 500 fluctuated between small gains and losses [1] - The sell-off in tech stocks has led to weekly losses of over 1% for the Dow, S&P 500, and Nasdaq [4] Company Earnings - Applied Materials (AMAT) saw its stock surge over 10% due to an upbeat outlook driven by robust AI demand [5] - Rivian (RIVN) shares jumped more than 20% following a fourth-quarter earnings beat, with the company on track to deliver its R2 midsize model before summer [6] - Moderna (MRNA) shares surged 10% after exceeding quarterly revenue estimates, attributed to strong sales of its Covid vaccine [6] - Pinterest (PINS) shares tumbled about 20% as revenue fell short, raising concerns about AI risks to its discovery platform [5]

Market Overview - US stocks experienced a rise on Friday, with the S&P 500 gaining approximately 0.6%, while the Dow Jones Industrial Average and Nasdaq Composite increased by roughly 0.4% and 0.5% respectively, despite being on track for weekly losses [1] Inflation Data - The Consumer Price Index indicated that consumer prices rose by 0.2% in January compared to the previous month and increased by 2.4% year-over-year, reflecting a cooler-than-expected inflation reading [2] Federal Reserve Expectations - The inflation report is expected to influence Federal Reserve policy, with traders increasing bets on a potential quarter-point interest rate cut in June, while most anticipate two cuts by the end of 2026 [3] Sector Performance - The market saw significant selling pressure due to concerns about AI disruption affecting traditional sectors like real estate, logistics, and transportation, leading to sharp weekly losses for the Dow, S&P 500, and Nasdaq [4] Earnings Reports - Applied Materials (AMAT) stock surged by up to 10% following a positive outlook driven by strong AI demand, while Pinterest (PINS) shares fell by as much as 20% due to revenue shortfalls and concerns over AI risks [5] - Rivian (RIVN) shares increased by over 25% after beating fourth-quarter earnings expectations, with plans for its R2 midsize model to be delivered before summer, and Moderna (MRNA) shares rose by 10% after exceeding quarterly revenue estimates due to strong sales of its Covid vaccine [6]

RFK Jr. ally cites childhood deaths after receiving Covid shot, but doesn’t provide evidence. https://t.co/AqKtltR9Mw ...

RFK Jr. ally cites childhood deaths after receiving Covid shot, but doesn’t provide evidence. https://t.co/i0woU0fXG5 ...

Breaking: RFK Jr.'s vaccine panel voted to stop recommending that Americans get the Covid shot, encouraging “individual decision-making" instead https://t.co/AeaNQwCDDB ...

Moderna’s second-quarter loss was narrower than Wall Street expected as the struggling biotech company cuts costs to offset waning sales of its Covid shot https://t.co/xDgt1BCeZy ...

A former Pfizer scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid shot data to hurt Trump’s 2020 election prospects https://t.co/1cR1Zt279N ...